Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
暂无分享,去创建一个
[1] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[2] W. Geldenhuys,et al. Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter. , 2004, Bioorganic & medicinal chemistry letters.
[3] P. Lockman,et al. The Transport of Choline , 2002, Drug development and industrial pharmacy.
[4] E. Lien,et al. Structure–activity relationship: analyses of p‐glycoprotein substrates and inhibitors , 2003, Journal of clinical pharmacy and therapeutics.
[5] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[6] Peter W. Swaan,et al. Structural Determinants of P-Glycoprotein-Mediated Transport of Glucocorticoids , 2003, Pharmaceutical Research.
[7] W. Pardridge,et al. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain. , 2003, Current opinion in drug discovery & development.
[8] U. Norinder,et al. Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.
[9] I. Tamai,et al. Transporter-mediated permeation of drugs across the blood-brain barrier. , 2000, Journal of pharmaceutical sciences.
[10] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[11] G. Goldenberg,et al. Membrane transport of alkylating agents. , 1980, Pharmacology & therapeutics.
[12] W. Pardridge. Molecular biology of the blood-brain barrier. , 2005, Molecular biotechnology.
[13] Gerry McDermott,et al. Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump , 2003, Science.
[14] Y. Sawada,et al. Characteristics of Choline Transport Across the Blood-Brain Barrier in Mice: Correlation with In Vitro Data , 2000, Pharmaceutical Research.
[15] S. Ekins,et al. Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein. , 2002, Molecular pharmacology.
[16] A. Garnier-Suillerot,et al. A Structural Model for the Open Conformation of the mdr1 P-glycoprotein Based on the MsbA Crystal Structure* , 2003, Journal of Biological Chemistry.
[17] Ingebrigt Sylte,et al. Molecular model of the neural dopamine transporter , 2003, J. Comput. Aided Mol. Des..
[18] J R Chretien,et al. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. , 1998, Journal of drug targeting.
[19] P. Lockman,et al. The blood-brain barrier choline transporter as a brain drug delivery vector. , 2003, Life sciences.
[20] A. Ravna,et al. Structures and Models of Transporter Proteins , 2004, Journal of Pharmacology and Experimental Therapeutics.
[21] S. Ekins,et al. Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates. , 2002, Molecular pharmacology.
[22] R. Bendayan,et al. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. , 2001, Pharmacological reviews.
[23] B. McEwen,et al. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. , 2001, Annual review of pharmacology and toxicology.
[24] Takashi Okuda,et al. Identification and characterization of the high-affinity choline transporter , 2000, Nature Neuroscience.
[25] M. Brightman,et al. Morphology of blood-brain interfaces. , 1977, Experimental eye research.
[26] Emi Nakashima,et al. New approaches to in vitro models of blood-brain barrier drug transport. , 2003, Drug discovery today.
[27] A. Ray,et al. In silico strategies for modeling membrane transporter function. , 2005, Drug discovery today.
[28] N. Shaik,et al. Drug efflux transporters in the CNS. , 2003, Advanced drug delivery reviews.
[29] D. E. Clark. In silico prediction of blood-brain barrier permeation. , 2003, Drug discovery today.
[30] W. Pardridge. Blood-brain barrier drug targeting: the future of brain drug development. , 2003, Molecular interventions.
[31] D. Dwyer. Molecular modeling and molecular dynamics simulations of membrane transporter proteins. , 2003, Methods in molecular biology.